🔎 Trials Near Me

Hjem › Neuroblastom › Colorado › Aurora

Neuroblastom kliniske forsøg i Aurora, CO

8 studier for Neuroblastom søger deltagere på steder i og omkring Aurora (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RekruttererFase 3
  • Children's Hospital Colorado, Aurora
Op til 30 år · Alle køn · Opdateret 2. okt. 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RekruttererFase 1/2
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora
6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RekruttererFase 3
  • Children's Hospital Colorado, Aurora
365 Days – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekruttererFase 1/2
  • Children's Hospital Colorado, Aurora
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

RekruttererFase 2
  • Children's Hospital Colorado, Aurora
Alder 1 til 31 · Alle køn · Opdateret 20. jul. 2026 · NCT06450041

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RekruttererFase 1/2
  • Children's Hospital Colorado, Aurora
12 Months – 30 Years · Alle køn · Opdateret 19. maj 2026 · NCT04901702

Neuroblastoma Biology Study

RekruttererObservationsstudie
  • Children Hospital of Colorado, Aurora
31 Days – 99 Years · Alle køn · Opdateret 23. mar. 2026 · NCT01587300

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RekruttererFase 2
  • Children's Hospital of Colorado, Aurora
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975

Neuroblastom forsøg i andre byer

Andre studier i Aurora

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.